Abstract: TH-PO835

Patient-Reported Advantages and Disadvantages of Peritoneal Dialysis: Results from the Peritoneal Dialysis Outcomes and Practice Patterns Study (PDOPPS)

Session Information

  • Peritoneal Dialysis - I
    November 02, 2017 | Location: Hall H, Morial Convention Center
    Abstract Time: 10:00 AM - 10:00 AM

Category: Dialysis

  • 608 Peritoneal Dialysis

Authors

  • Perl, Jeffrey, St. Michael's Hospital, Toronto, Ontario, Canada
  • Tomo, Tadashi, Oita University Hospital, Yufu, Japan
  • Morton, Rachael L., The University of Sydney, Sydney, New South Wales, Australia
  • Robinson, Bruce M., Arbor Research Collaborative for Health, Ann Arbor, Michigan, United States
  • Zhao, Junhui, Arbor Research Collaborative for Health, Ann Arbor, Michigan, United States
  • Fuller, Douglas S., Arbor Research Collaborative for Health, Ann Arbor, Michigan, United States
  • Bieber, Brian, Arbor Research Collaborative for Health, Ann Arbor, Michigan, United States
  • Sloand, James A., Baxter Healthcare Corporation, Deerfield, Illinois, United States
  • Subramanian, Lalita, Arbor Research Collaborative for Health, Ann Arbor, Michigan, United States
  • Johnson, David W., Princess Alexandra Hospital, Brisbane, Queensland, Australia
  • Oliver, Matthew J., Sunnybrook Health Sciences Center, Toronto, Ontario, Canada
  • Tungsanga, Kriang, King Chulalong Memorial lHospital, Bangkok, Thailand

Group or Team Name

  • On behalf of clinical application of PD therapy working group
Background

Compared to facility-based hemodialysis, home-based peritoneal dialysis (PD) may offer patients advantages and disadvantages. We sought to better understand patient-reported perceptions of the advantages and disadvantages of PD treatment.

Methods

PDOPPS is a prospective cohort study of PD treatment and outcomes in Australia, Canada, Japan, New Zealand, Thailand, the United Kingdom (UK) and the United States (US). Opinions on how PD treatment impacts 17 aspects of daily life were assessed using the self-reported PDOPPS patient questionnaire (PQ).

Results

Between 2014 and 2017, 2641 patients returned a PQ; item-level response rates ranged from 88% to 96%. Among the 11 factors of expected advantages (Figure 1A), "receive treatment at home" was most commonly perceived as an advantage (95%), followed by “do not require accessing of blood" (89%). The most commonly cited disadvantages of PD treatments were “feeling full with PD fluid in abdomen” (43%) and "space taken up by PD supplies" (overall 33%, Figure 1B), which was particularly regarded as a disadvantage by patients in UK (53%), Canada (40%), US (36%), vs. 16-32% elsewhere. Fewer patients in Japan and Thailand (28% and 43%, respectively, compared to over 57-67% elsewhere) perceived “able to travel more easily” as an advantage of PD.

Conclusion

Abdominal fullness and space taken up by PD supplies appear to be concerns for a substantial minority of patients receiving PD, while treatment receipt at home obviating the need for accessing blood appear to be the predominant advantages. Better understanding of the patient, treatment and regional variation associated with these concerns may provide insights into improving the patient experience of PD and allow for more informed dialysis modality education.

Funding

  • Commercial Support